Non-informative “profiles” [General Sta­tis­tics]

posted by Helmut Homepage – Vienna, Austria, 2014-03-11 18:22 (4064 d 12:37 ago) – Posting: # 12600
Views: 10,152

Hi Fabrice,

❝ The context is the following:

❝ – Phase IIa multiple-dose placebo-controlled study, so only one active treatment

❝ – Oral inhalation, resulting in quite high inter- and intra-patient PK variability


This was one of the possibilities I suspected. ;-) Let’s see whether our specialist for OIPs (ElMaestro) will join the party…

❝ The study is thus not at risk :cool: from a PK point of view.

❝ But I was nevertheless interested on what would be the suggestions to best handle such a situation from a pure statistical point of view.


OK, I think cards are stacked against you if you want to stick to NCA only. PK modeling (or even PopPK/PD if you are courageous) with censored data might be helpful if you face a lot of missing data.

❝ For PK, the potential impact is on the steady-state vs single dose comparison, but you can also simply consider the computation of the descriptive geometric mean Cmax and AUC... how to best deal with a zero value?


Too bad that ln(0) is undefined…

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,667 registered users;
22 visitors (0 registered, 22 guests [including 8 identified bots]).
Forum time: 08:00 CEST (Europe/Vienna)

It is true that many scientists are not philosophically minded
and have hitherto shown much skill and ingenuity
but little wisdom.    Max Born

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5